Sera Prognostics, Inc. Profile
Industry
Medical - Diagnostics & ResearchSector
HealthcareNumber of Employees
55Sera Prognostics's Business Model
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
About Sera Prognostics
Website: https://seraprognostics.com
CEO (Chief Executive Officer): Ms. Evguenia Lindgardt M.B.A.
IPO date: 2021-07-15
Contact
Country: US
Address: 2749 East Parleys Way
City: Salt Lake City
State: UT
Phone: 801 990 0520
Zip Code: 84109
Other
CIK: 0001534969
ISIN: US81749D1072
CUSIP: 81749D107
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
